Evidence
Life Sci. 2024 Jan 17:122431. doi: 10.1016/j.lfs.2024.122431. Online ahead of print.
ABSTRACT
Liver disease has become one of the main causes of health issue worldwide. Sirtuin (Sirt) 2 is a nicotinamide adenine dinucleotide (NAD+)-dependent deacetylase, and is expressed in multiple organs including liver, which plays important and complex roles by interacting with various substrates. Physiologically, Sirt2 can improve metabolic homeostasis. Pathologically, Sirt2 can alleviate inflammation, endoplasmic reticulum (ER) stress, promote liver regeneration, maintain iron homeostasis, aggravate fibrogenesis and regulate oxidative stress in liver. In liver diseases, Sirt2 can mitigate fatty liver disease (FLD) including non-alcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD), but aggravate hepatitis B (HBV) and liver ischemia-reperfusion injury (LIRI). The role of Sirt2 in liver cancer and aging-related liver diseases, however, has not been fully elucidated. In this review, these biological processes regulated by Sirt2 in liver are summarized, which aims to update the function of Sirt2 in liver and to explore the potential role of Sirt2 as a therapeutic target for liver diseases.
PMID:38242495 | DOI:10.1016/j.lfs.2024.122431
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
The role of Sirtuin 2 in liver – An extensive and complex biological process
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Polysaccharide of Atractylodes macrocephala Koidz alleviates NAFLD-induced hepatic inflammation in mice by modulating the TLR4/MyD88/NF-κB pathway
- Polysaccharide of Atractylodes macrocephala Koidz alleviates NAFLD-induced hepatic inflammation in mice by modulating the TLR4/MyD88/NF-κB pathway
- Oxidative stress in alcoholic liver disease, focusing on proteins, nucleic acids, and lipids: A review
- GA receptor targeted chitosan oligosaccharide polymer nanoparticles improve non-alcoholic fatty liver disease by inhibiting ferroptosis
- Alcohol- and Low-Iron Induced Changes in Antioxidant and Energy Metabolism Associated with Protein Lys Acetylation
- Chiglitazar attenuates high-fat diet-induced nonalcoholic fatty liver disease by modulating multiple pathways in mice
- Trimethylamine N-oxide Induces Non-alcoholic Fatty Liver Disease by Activating the PERK Signaling Pathway
- Trimethylamine N-oxide Induces Non-alcoholic Fatty Liver Disease by Activating the PERK Signaling Pathway
- The Beneficial Effect of Brazilian Propolis for Liver Damage through Endoplasmic Reticulum Stress
- From non-alcoholic fatty liver disease to metabolic-associated steatotic liver disease: Rationale and implications for the new terminology
- Association between nonalcoholic steatohepatitis and high serum ferritin levels in type 2 diabetes mellitus
- Exerkines: Benign adaptation for exercise and benefits for non-alcoholic fatty liver disease
- Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
- Effects of Marine Natural Products on Liver Diseases
- The rs1862513 promoter variant of resistin gene influences susceptibility to nonalcoholic fatty liver disease
- Western Diet-Induced Nonalcoholic Fatty Liver Disease Mice Mimic the Key Transcriptomic Signatures Observed in Humans
- Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact
- Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome
- Hepatic lipopolysaccharide binding protein partially uncouples inflammation from fibrosis in MAFLD
- Discovery of genomic loci for liver health and steatosis reveals overlap with glutathione redox genetics
- Hepatic miR-363 promotes non-alcoholic fatty liver disease by suppressing INSIG1
- Paricalcitol attenuates oxidative stress and inflammatory response in the liver of NAFLD rats by regulating FOXO3a and NFκB acetylation
- Non-Alcoholic Fatty Liver Disease, Atherosclerosis, and Cardiovascular Disease in Asia
- Non-Alcoholic Fatty Liver Disease, Atherosclerosis, and Cardiovascular Disease in Asia
- Role of HSP90 in Type 2 Diabetes Mellitus and Its Association with Liver Diseases
- Haloacetamides disinfection by-products, a potential risk factor for nonalcoholic fatty liver disease
- Emerging roles of liquid-liquid phase separation in liver innate immunity
- Therapeutic potential of palmitoleic acid in non-alcoholic fatty liver disease: Targeting ferroptosis and lipid metabolism disorders
- Sesaminol alters phospholipid metabolism and alleviates obesity-induced NAFLD
- Natural history and progression of metabolic dysfunction-associated steatotic liver disease
- Key regulators of hepatic stellate cell activation in alcohol liver Disease: A comprehensive review
- Intricate interplay between cell metabolism and necroptosis regulation in metabolic dysfunction-associated steatotic liver disease: A narrative review
- Oleuropein mitigates non-alcoholic fatty liver disease (NAFLD) and modulates liver metabolites in high-fat diet-induced obese mice via activating PPARalpha
- Oleuropein mitigates non-alcoholic fatty liver disease (NAFLD) and modulates liver metabolites in high-fat diet-induced obese mice via activating PPARalpha
- The burden of non-alcoholic fatty liver disease in Australia: an analysis of Global Burden of Disease study from 1990 to 2019
- Prevalence of nonalcoholic fatty liver disease in Pakistan: a systematic review and meta-analysis
- Prevalence of nonalcoholic fatty liver disease in Pakistan: a systematic review and meta-analysis
- Current and experimental pharmacotherapy for the management of non-alcoholic fatty liver disease
- Key role of interferon regulatory factor 1 (IRF-1) in regulating liver disease: progress and outlook
- Liver Fatty Acid-binding Protein Is a More Reliable Biomarker for Liver Injury in Nonalcoholic Steatohepatitis than Other Etiologies of Hepatitis
- A preclinical model of severe NASH-like liver injury by chronic administration of a high-fat and high-sucrose diet in mice
- The potential role of Akkermansia muciniphila in liver health
- Targeting cell death in NAFLD: mechanisms and targeted therapies
- Adaptation of Clinical Practice Guideline for Assessment of Liver Fibrosis in Patients with Non Alcoholic Fatty Liver Disease in Isfahan Province
- Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes
- Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes
- miR-33 deletion in hepatocytes attenuates NAFLD-NASH-HCC progression
- Exploring factors associated with non-alcoholic fatty liver disease using longitudinal MRI
- Exploring factors associated with non-alcoholic fatty liver disease using longitudinal MRI
- Exploring factors associated with non-alcoholic fatty liver disease using longitudinal MRI
- Gut-liver axis: Potential mechanisms of action of food-derived extracellular vesicles
- Vaccinium spp. Berries in the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Update of Preclinical and Clinical Research
- Vaccinium spp. Berries in the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Update of Preclinical and Clinical Research
- Relationship between Neutrophil-to-Lymphocyte Ratio and Liver Fibrosis in Nonalcoholic Fatty Liver Disease Among Adults in the United States: Data from the National Health and Nutrition Examination Survey 2017-2018
- Prevalence and Association of Risk Factors According to Liver Steatosis and Fibrosis Stages among Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus in India: A Cross-sectional Study
- Serum Metabolomics Uncovers the Mechanisms of Inulin in Preventing Non-Alcoholic Fatty Liver Disease
- Hepatoprotective effects of diosmin: a narrative review
- Hepatoprotective effects of diosmin: a narrative review
- MAFLD in adults: non-invasive tests for diagnosis and monitoring of MAFLD
- Effects of Mao tea from Nankun Mountain on nonalcoholic fatty liver disease in mice
- Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation
- Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation
- Effect of statin use on liver enzymes and lipid profile in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
- Effect of statin use on liver enzymes and lipid profile in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
Evidence Blueprint
The role of Sirtuin 2 in liver – An extensive and complex biological process
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
The role of Sirtuin 2 in liver – An extensive and complex biological process
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Effect of the nomenclature of non-alcoholic fatty liver disease on diagnosis and treatment of fatty liver disease concomitant with other liver diseases
- Polysaccharide of Atractylodes macrocephala Koidz alleviates NAFLD-induced hepatic inflammation in mice by modulating the TLR4/MyD88/NF-κB pathway
- Polysaccharide of Atractylodes macrocephala Koidz alleviates NAFLD-induced hepatic inflammation in mice by modulating the TLR4/MyD88/NF-κB pathway
- Oxidative stress in alcoholic liver disease, focusing on proteins, nucleic acids, and lipids: A review
- GA receptor targeted chitosan oligosaccharide polymer nanoparticles improve non-alcoholic fatty liver disease by inhibiting ferroptosis
- Adipose-derived extracellular vesicles - a novel cross-talk mechanism in insulin resistance, non-alcoholic fatty liver disease, and polycystic ovary syndrome
- Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy
- Emerging roles of RNA-binding proteins in fatty liver disease
- Research progress in the regulation of pathogenesis and the transformation of chronic liver disease by short-chain fatty acids
- Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology
- The role and mechanism of SUMO modification in liver disease
- Structure-Activity Studies of 1,2,4-Oxadiazoles for the Inhibition of the NAD+-Dependent Lysine Deacylase Sirtuin 2
- Structure-Activity Studies of 1,2,4-Oxadiazoles for the Inhibition of the NAD+-Dependent Lysine Deacylase Sirtuin 2
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- SHMT2 reduces fatty liver but is necessary for liver inflammation and fibrosis in mice
- SHMT2 reduces fatty liver but is necessary for liver inflammation and fibrosis in mice
- Fatty liver disease's renaming impacts on drug clinical trials
- Insights into the role of vitamin D in targeting the culprits of non-alcoholic fatty liver disease
- Endoplasmic reticulum stress in the pathogenesis of alcoholic liver disease
- Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction
- Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth
- Alcohol- and Low-Iron Induced Changes in Antioxidant and Energy Metabolism Associated with Protein Lys Acetylation
- The Transition in Terminology: From Non-alcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) to Metabolic-associated Steatotic Liver Disease (MASLD)
- The gut-liver axis in fatty liver disease: role played by natural products
- Role of FXR in the development of NAFLD and intervention strategies of small molecules
- Puerarin protects the fatty liver from ischemia-reperfusion injury by regulating the PI3K/AKT signaling pathway
- The role of N6-methyladenosine methyltransferase RBM15 in non-alcoholic fatty liver disease
- Glycyrrhizin and the Related Preparations: An Inspiring Resource for the Treatment of Liver Diseases
- Multiscale 3D genome organization underlies duck fatty liver with no adipose inflammation or serious injury
- Inflammatory liver diseases and susceptibility to sepsis
- Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications
- NLRP3 inflammasome in hepatic diseases: A pharmacological target
- Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
- Chiglitazar attenuates high-fat diet-induced nonalcoholic fatty liver disease by modulating multiple pathways in mice
- Trimethylamine N-oxide Induces Non-alcoholic Fatty Liver Disease by Activating the PERK Signaling Pathway
- Trimethylamine N-oxide Induces Non-alcoholic Fatty Liver Disease by Activating the PERK Signaling Pathway
- Various types of fasting diet and possible benefits in nonalcoholic fatty liver: Mechanism of actions and literature update
- The Beneficial Effect of Brazilian Propolis for Liver Damage through Endoplasmic Reticulum Stress
- Highland barley β-glucan supplementation attenuated hepatic lipid accumulation in Western diet-induced non-alcoholic fatty liver disease mice by modulating gut microbiota
- Metabolic Dysfunction-associated Fatty Liver Disease: An Urgent Call for Global Action
- Akkermansia muciniphila - a Potential Next-generation Probiotic for Non-alcoholic Fatty Liver Disease
- Role of prostaglandin E2 and its receptors in chronic liver disease
- The role of endoplasmic reticulum stress-related genes in the diagnosis and subtyping of non-alcoholic fatty liver disease
- Metabolic study of iron deposition based on magnetic resonance in patients with nonalcoholic fatty liver disease
- Corrected and republished from: Metabolic associated liver disease
- Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease
- From non-alcoholic fatty liver disease to metabolic-associated steatotic liver disease: Rationale and implications for the new terminology
- Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities
- Association between nonalcoholic steatohepatitis and high serum ferritin levels in type 2 diabetes mellitus
- Exerkines: Benign adaptation for exercise and benefits for non-alcoholic fatty liver disease
- Role of lactate and lactate metabolism in liver diseases (Review)
- Non-alcoholic fatty liver disease and periodontal disease: A systematic review and meta-analysis of cross-sectional studies
- Activating transcription factor (ATF) 6 upregulates cystathionine β synthetase (CBS) expression and hydrogen sulfide (H2S) synthesis to ameliorate liver metabolic damage
- Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12
- Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12
- Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
- Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies
- Review and expert opinion on MAFLD, oxidative stress and multifunctional management
- Research progress of celastrol on the prevention and treatment of metabolic associated fatty liver disease
- Increased Risk of Colorectal Adenomas with Metabolic-Associated Fatty Liver Disease Components
- Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
- Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma
- Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics